Link Details
- Metabolite
- HMDB0000122 (D-Glucose)
- DrugBank ID
- DB01276
- Drug Name
- Exenatide
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Harris KB, Boland CL: Adjunctive Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Type 1 Diabetes Mellitus. Pharmacotherapy. 2016 Sep;36(9):1011-20. doi: 10.1002/phar.1804. Epub 2016 Sep 1. [PubMed:27485823 ]
- Berg JK, Shenouda SK, Heilmann CR, Gray AL, Holcombe JH: Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study. Diabetes Obes Metab. 2011 Nov;13(11):982-9. doi: 10.1111/j.1463-1326.2011.01428.x. [PubMed:21615670 ]
- Fineman M, Flanagan S, Taylor K, Aisporna M, Shen LZ, Mace KF, Walsh B, Diamant M, Cirincione B, Kothare P, Li WI, MacConell L: Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing. Clin Pharmacokinet. 2011 Jan;50(1):65-74. doi: 10.2165/11585880-000000000-00000. [PubMed:21142268 ]
- Taylor K, Kim D, Nielsen LL, Aisporna M, Baron AD, Fineman MS: Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes. Horm Metab Res. 2005 Oct;37(10):627-32. [PubMed:16278786 ]
- Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG: Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2005 Oct 18;143(8):559-69. [PubMed:16230722 ]